Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Porcine circovirus type 2 (PCV2) capsid protein, encoded by the ORF2 gene, is the sole structural component of the PCV2 virion and the primary target for the host's protective immune response (UniProt P0C6V4). It self-assembles into virus-like particles (VLPs) that display critical neutralizing epitopes on their surface, particularly within the loops connecting the beta-strands of the jelly-roll fold. These epitopes are essential for binding to host cell receptors such as heparan sulfate proteoglycans and facilitating viral entry into porcine cells.
In the context of porcine circovirus associated disease (PCVAD), this protein is the central focus of preventive veterinary medicine, serving as the active antigen in most commercial subunit vaccines like Ingelvac Circoflex. These vaccines aim to elicit neutralizing antibodies that block viral attachment and replication, thereby reducing clinical symptoms and viral shedding in swine populations. However, the high mutation rate of the PCV2 genome leads to significant antigenic drift, particularly in the surface-exposed loops of the capsid protein, posing a continuous challenge for vaccine efficacy and necessitating the development of multi-genotype or chimeric VLP-based therapeutics.
Induction of humoral and cellular immune responses, specifically neutralizing antibodies that block viral attachment to host cell receptors (such as heparan sulfate) and inhibit viral entry into host macrophages and lymphocytes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Porcine circovirus type 2 capsid protein (PCV2 Cap).